PDUFA V: FDA Offers Mid-Cycle Review Talks, But Industry Wants Them Later

As negotiations about the next user fee cycle continue, FDA is offering an opportunity for sponsors to formally discuss an application's progress with reviewers, although it appears the new proposed meeting would come too early in the process for industry’s satisfaction.